Ian Wilding

Photopharmica Ltd. develops and discovers novel photosensitizer products. Its products pipeline includes phenothiazinium photosensitizers for use as topical therapeutic antimicrobial agents and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization. The firm's light-activated drugs kill common disease-causing microorganisms including Gram positive and negative bacteria. The company was founded in 2001 by John Lyon and is headquartered in Leeds, the United Kingdom.

Prophilian Ltd. is a technology investment company. The compnay provides marketing as well as commercial and financial management services to pharmaceutical and biotechnology companies in Europe, North America, and Japan. Prophilian is headquartered in Ruddington, UK.

Pharmaceutical Profiles Ltd. develops drugs for pharmaceutical and biotech companies. The company studies how drugs are absorbed and processed in the human body. It utilizes gamma camera imaging products in its studies. It also provides complete scientific, regulatory and medical support for its client's clinical development programs. Pharmaceutical Profiles was founded in 1990 and is headquartered in Nottingham, UK.

Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom.

Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom.

Zysis Ltd. manufactures drug reformulation services. It offers therapies for disorders of the central nervous system to improve sufferers lives. The company was founded in November 21, 2005 and is headquartered in London, the Unite Kingdom.